119 related articles for article (PubMed ID: 9175716)
1. Comet assay studies on the activation of two diaziridinylbenzoquinones in K562 cells.
Ward TH; Butler J; Shahbakhti H; Richards JT
Biochem Pharmacol; 1997 Apr; 53(8):1115-21. PubMed ID: 9175716
[TBL] [Abstract][Full Text] [Related]
2. Cross-resistance studies on two K562 sublines resistant to diaziridinylbenzoquinones.
Ward TH; Haran MS; Whittaker D; Watson AJ; Howard TD; Butler J
Biochem Pharmacol; 1995 Aug; 50(4):459-64. PubMed ID: 7646550
[TBL] [Abstract][Full Text] [Related]
3. Induction of DNA strand breaks and cross-links by 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone in Chinese hamster ovary cells.
King CL; Hittelman WN; Loo TL
Cancer Res; 1984 Dec; 44(12 Pt 1):5634-7. PubMed ID: 6498824
[TBL] [Abstract][Full Text] [Related]
4. DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction.
Hartley JA; Berardini M; Ponti M; Gibson NW; Thompson AS; Thurston DE; Hoey BM; Butler J
Biochemistry; 1991 Dec; 30(50):11719-24. PubMed ID: 1751490
[TBL] [Abstract][Full Text] [Related]
5. The lack of correlation between toxicity and free radical formation of two diaziridinyl benzoquinones.
Lea JS; Garner HJ; Butler J; Hoey BM; Ward TH
Biochem Pharmacol; 1988 May; 37(10):2023-5. PubMed ID: 2837220
[TBL] [Abstract][Full Text] [Related]
6. Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial.
Danson S; Ranson M; Denneny O; Cummings J; Ward TH
Cancer Chemother Pharmacol; 2007 Nov; 60(6):851-61. PubMed ID: 17333193
[TBL] [Abstract][Full Text] [Related]
7. Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).
King CL; Wong SK; Loo TL
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):261-4. PubMed ID: 6538490
[TBL] [Abstract][Full Text] [Related]
8. The reduction of anti-tumour diaziridinyl benzoquinones.
Butler J; Hoey BM; Lea JS
Biochim Biophys Acta; 1987 Aug; 925(2):144-9. PubMed ID: 3040109
[TBL] [Abstract][Full Text] [Related]
9. The alkylation of DNA in vitro by 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinyl-1,4-benzoquinone (BZQ)--I.
Butler J; Hoey BM; Ward TH
Biochem Pharmacol; 1989 Mar; 38(6):923-7. PubMed ID: 2930592
[TBL] [Abstract][Full Text] [Related]
10. Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.
Gibson NW; Hartley JA; Butler J; Siegel D; Ross D
Mol Pharmacol; 1992 Sep; 42(3):531-6. PubMed ID: 1406604
[TBL] [Abstract][Full Text] [Related]
11. Differential cytotoxicity of diaziquone toward Chinese hamster ovary cells under hypoxic and aerobic exposure conditions.
O'Brien PJ; Kaul HK; Rauth AM
Cancer Res; 1990 Mar; 50(5):1516-20. PubMed ID: 2302714
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial toxicity of 2,5-diaziridinyl-3,6-bis-(carboethoxyamino)-1,4-benzoquinone.
Oberc-Greenwood MA; Smith BH; Cooke C; Ellis JR; Kornblith PL; McKeever PE
J Natl Cancer Inst; 1983 Oct; 71(4):725-33. PubMed ID: 6578368
[TBL] [Abstract][Full Text] [Related]
13. Photosensitization of MCF-7 cells with diaziquone using visible light: correlation with DNA strand breaks and free radical production.
al-Nabulsi I; Gutierrez PL
Photochem Photobiol; 1992 Aug; 56(2):201-9. PubMed ID: 1502264
[TBL] [Abstract][Full Text] [Related]
14. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
Szmigiero L; Erickson LC; Ewig RA; Kohn KW
Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204
[TBL] [Abstract][Full Text] [Related]
15. Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymatic reduction by DT-diaphorase.
Lee CS; Hartley JA; Berardini MD; Butler J; Siegel D; Ross D; Gibson NW
Biochemistry; 1992 Mar; 31(11):3019-25. PubMed ID: 1372518
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of the pharmacodynamic properties of 2,5-diaziridinyl-3-hydroxymethyl-6-methyl-1,4-benzoquinone.
Ward TH; Danson S; McGown AT; Ranson M; Coe NA; Jayson GC; Cummings J; Hargreaves RH; Butler J
Clin Cancer Res; 2005 Apr; 11(7):2695-701. PubMed ID: 15814651
[TBL] [Abstract][Full Text] [Related]
17. Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone.
Ngo EO; Nutter LM; Sura T; Gutierrez PL
Chem Res Toxicol; 1998 Apr; 11(4):360-8. PubMed ID: 9548807
[TBL] [Abstract][Full Text] [Related]
18. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
[TBL] [Abstract][Full Text] [Related]
19. Contrasting cytotoxic mechanisms of similar antitumour diaziridinylbenzoquinones.
Butler J; Dzielendziak A; Lea JS; Ward TH; Hoey BM
Free Radic Res Commun; 1990; 8(4-6):231-9. PubMed ID: 2162311
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
Szmigiero L; Kohn KW
Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
